![Spiros D. Garbis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Spiros D. Garbis
Entité | Type d'entité | Industrie | |
---|---|---|---|
Proteas Bioanalytics, Inc.
![]() Proteas Bioanalytics, Inc. Internet Software/ServicesTechnology Services Proteas Bioanalytics, Inc. is an innovative proteomics platform that advances molecular biology, biomarker development, and precision medicine. The private company is based in Torrance, CA and was founded by Spiros D. Garbis and Antigoni Manousopoulou. The company provides proteomics services and solutions to unmet needs in the field of neurodegenerative disorders, coronary artery disease, and cancer. Proteas Bioanalytics has collaborated with thought leaders and innovators in the medical field to develop novel blood biomarkers that are predictive of the progression from pre-malignant to active myeloma. Spiros D. Garbis has been the CEO since incorporation.
3
| Private Company | Internet Software/Services | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Spiros D. Garbis via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Thuris Corp.
![]() Thuris Corp. Medical SpecialtiesHealth Technology Thuris Corp. develops medical devices. It develops pharmaceuticals for CNS Orphan and niche indications including, a stroke-related condition, peripheral neuropathy and Huntington's disease. It develops pharmaceuticals for cluster headaches, depression and mild cognitive impairment, a precursor of Alzheimer's disease. The company is also developing a non-invasive medical device that will assist in the diagnosis of psychiatric and neurological disorders over a broad range of brain-related conditions. Thuris is headquartered in Irvine, CA. | Medical Specialties | Chief Operating Officer | |
University of California, Irvine | College/University | Doctorate Degree | |
RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ancile Pharmaceuticals, Inc.
![]() Ancile Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ancile Pharmaceuticals, Inc. develops and manufactures pharmaceuticals. The private company is based in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Athos Therapeutics, Inc.
![]() Athos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Athos Therapeutics, Inc. is a biotech company based in Torrance, CA. Athos Therapeutics develops small molecule therapeutics for immune-mediated diseases using artificial intelligence-generated innovative chemistry and computational platforms. The private company identifies novel drug targets by integrating clinical and molecular datasets into the biological network of a disease and matches them to its small molecule computational chemistry platform. Ath-63, the company's lead drug compound, is moving into a phase I human clinical trial for patients with inflammatory bowel disease in Q1 2022 at the Cleveland Clinic. Other pipeline programs include drugs for lupus and various types of cancers. The company was founded in 2019 by Michael Jung, Allan J. Pantuck, and Dimitrios Iliopoulos, who has been the CEO since then. | Pharmaceuticals: Major | Chief Executive Officer | |
MedicusData.Ai, Inc.
![]() MedicusData.Ai, Inc. Packaged SoftwareTechnology Services Dyania Health, Inc. develops a clinical research platform for pharmacies and hospitals. The company is based in Los Angeles, CA. The company was founded by Eirini Schlosser and Dimitrios Iliopoulos. Eirini Schlosser has been the CEO since incorporation. | Packaged Software | Founder |
Statistiques
Internationale
Etats-Unis | 8 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Commercial Services | 2 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Founder | 3 |
Chief Operating Officer | 1 |
Doctorate Degree | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Spiros D. Garbis
- Connexions Sociétés